Research Topics
| HUGH SWEENEYSummaryAffiliation: University of Pennsylvania Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Kinetic tuning of myosin via a flexible loop adjacent to the nucleotide binding pocketH L Sweeney
Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
J Biol Chem 273:6262-70. 1998..In addition, the rate of ATP hydrolysis is slowed...
Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin functionH L Sweeney
Department of Physiology, A700 Richards Building, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6085, USA
Proc Natl Acad Sci U S A 95:14406-10. 1998..Furthermore, these data suggest that these TnT mutations may cause disease via an increased energetic load on the heart. This would represent a second paradigm for HCM pathogenesis...
Regulation of asymmetric smooth muscle myosin II moleculesH L Sweeney
Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 6085, USA
J Biol Chem 275:41273-7. 2000..This may be part of the mechanism underlying "latch" in smooth muscle...
What can myosin VI do in cells?H Lee Sweeney
Department of Physiology University of Pennsylvania School of Medicine, 3700 Hamilton Walk, Philadelphia, PA 19104 6085 USA
Curr Opin Cell Biol 19:57-66. 2007..These mechanistic insights allow us to speculate on how unusual aspects of myosin VI structure and function allow it to fill unique niches in cells...
Structural and functional insights into the Myosin motor mechanismH Lee Sweeney
Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 6085, USA
Annu Rev Biophys 39:539-57. 2010..We also describe studies that delineate how some classes of myosin motors are adapted for processive movement on actin...
Myosin VI rewrites the rules for myosin motorsH Lee Sweeney
Department of Physiology, University of Pennsylvania School of Medicine, B700 Richards Building, 3700 Hamilton Walk, Philadelphia, PA 19104 6085, USA
Cell 141:573-82. 2010..Given that other classes of myosins may share some of these features, understanding the design principles of myosin VI will help guide the study of the functions of myosins that adopt similar strategies...
Systemic myostatin inhibition via liver-targeted gene transfer in normal and dystrophic miceKevin J Morine
Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America
PLoS ONE 5:e9176. 2010..Previously described approaches to blocking myostatin signaling include injection delivery of inhibitory propeptide domain or neutralizing antibodies...
Correction of the dystrophic phenotype by in vivo targeting of muscle progenitor cellsGary P Kobinger
Gene Therapy Program, Division of Medical Genetics, University of Pennsylvania Health System, Philadelphia, Pennsylvania 19104, USA
Hum Gene Ther 14:1441-9. 2003..This study shows that progenitor cells can be genetically engineered in vivo and subsequently proliferate into terminally differentiated tissue carrying the genetic graft in a way that stably corrects function...
Diaphragm displays early and progressive functional deficits in dysferlin-deficient miceElisabeth R Barton
Department of Anatomy and Cell Biology, School of Dental Medicine, 441A Levy Building, 240 S 40th Street, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
Muscle Nerve 42:22-9. 2010..These studies show that, unlike limb muscles, the diaphragm from the A/J mouse displays early deficits in function that may lower the age needed for evaluating potential therapies for dysferlinopathies...
Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failureVasant Jayasankar
Department of Cardiothoracic Surgery, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
J Card Surg 20:93-101. 2005..This technique may be useful to treat or prevent postinfarction heart failure...
Myostatin is upregulated following stress in an Erk-dependent manner and negatively regulates cardiomyocyte growth in culture and in a mouse modelLawrence T Bish
Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America
PLoS ONE 5:e10230. 2010..Myostatin is a negative regulator of cardiac growth, and further studies are warranted to investigate the role of myostatin in the healthy and failing heart...
Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathyY Joseph Woo
Division of Cardiothoracic Surgery, Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
J Thorac Cardiovasc Surg 130:321-9. 2005....
Activin IIB receptor blockade attenuates dystrophic pathology in a mouse model of Duchenne muscular dystrophyKevin J Morine
Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
Muscle Nerve 42:722-30. 2010..No effect on heart mass or function was observed. Our results indicate that activin IIB receptor blockade represents a novel and effective therapeutic strategy for the muscular dystrophies...
Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and ratLawrence T Bish
Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
Hum Gene Ther 19:1359-68. 2008..AAV9 should be used in rodent cardiac studies and may be the vector of choice for clinical trials of cardiac gene transfer...
Gene therapy in large animal models of human cardiovascular genetic diseaseMeg M Sleeper
Department of Clinical Studies, University of Pennsylvania Veterinary School, Philadelphia, PA, USA
ILAR J 50:199-205. 2009..g., calcium metabolism, apoptosis) could normalize diseased myocardial function. Gene therapy may offer a promising new approach for the treatment of cardiac disease in both veterinary and human clinical settings...
Status of therapeutic gene transfer to treat canine dilated cardiomyopathy in dogsMeg M Sleeper
Department of Clinical Studies, University of Pennsylvania Veterinary School, Philadelphia, PA 19104, USA
Vet Clin North Am Small Anim Pract 40:717-24. 2010..The authors are currently evaluating this approach to treat canine idiopathic dilated cardiomyopathy...
The motor mechanism of myosin V: insights for muscle contractionH Lee Sweeney
Department of Physiology, University of Pennsylvania School of Medicine, A700 Richards Building, 3700 Hamilton Walk, Philadelphia, PA 19104 6085, USA
Philos Trans R Soc Lond B Biol Sci 359:1829-41. 2004....
Blocking the development of postischemic cardiomyopathy with viral gene transfer of the apoptosis repressor with caspase recruitment domainSubhasis Chatterjee
Division of Cardiothoracic Surgery and Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
J Thorac Cardiovasc Surg 125:1461-9. 2003..Adenovirus-apoptosis repressor with caspase recruitment domain administration offers a potential strategy after myocardial ischemia to protect the heart from late postischemic cardiomyopathy...
One year transgene expression with adeno-associated virus cardiac gene transferY Joseph Woo
University of Pennsylvania Department of Surgery, Philadelphia, PA 19104, United States
Int J Cardiol 100:421-6. 2005..This study examined the feasibility of AAV-mediated myocardial gene transfer in mice, the animal which, because of transgenic technology, has become the disease model of choice for cardiovascular research...
Gene dopingH Lee Sweeney
University of Pennsylvania School of Medicine, USA
Sci Am 291:62-9. 2004
Viral gene transfer of the antiapoptotic factor Bcl-2 protects against chronic postischemic heart failureSubhasis Chatterjee
Division of Cardiothoracic Surgery, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
Circulation 106:I212-7. 2002..The benefit at 6 weeks is postulated to result from a Bcl-2-mediated reduction in apoptosis and ventricular remodeling. Adeno-Bcl-2 administration offers a potential strategy to protect the heart from late postischemic heart failure...
Calcium functionally uncouples the heads of myosin VICarl A Morris
Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 6085, USA
J Biol Chem 278:23324-30. 2003..Lastly, calmodulin mutants reveal that the calcium effect is dependent on calcium binding to the N-terminal lobe of calmodulin...
How myosin VI coordinates its heads during processive movementH Lee Sweeney
Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
EMBO J 26:2682-92. 2007..While this mechanism is unlike that of any other myosin superfamily member, it bears remarkable similarities to that of another processive motor from a different superfamily--kinesin I...
Functional role of loop 2 in myosin VChristopher M Yengo
Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 6085, USA
Biochemistry 43:2605-12. 2004..The ability to maintain a high affinity for actin in the weak binding states may prevent diffusion away from the actin filament and increase the degree of processive motion of myosin V...
Leupeptin-based inhibitors do not improve the mdx phenotypeJoshua Selsby
Department of Physiology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Am J Physiol Regul Integr Comp Physiol 299:R1192-201. 2010....
Kinetic characterization of the weak binding states of myosin VChristopher M Yengo
University of Pennsylvania School of Medicine, Department of Physiology and Pennsylvania Muscle Institute, Philadelphia, Pennsylvania 19104, USA
Biochemistry 41:8508-17. 2002....
Neovasculogenic therapy to augment perfusion and preserve viability in ischemic cardiomyopathyPavan Atluri
Division of Cardiothoracic Surgery, Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
Ann Thorac Surg 81:1728-36. 2006....
Kinetic mechanism of blebbistatin inhibition of nonmuscle myosin IIbBhagavathi Ramamurthy
Department of Physiology, University of Pennsylvania School of Medicine, 3700 Hamilton Walk, Philadelphia, Pennsylvania 19104-6085, USA
Biochemistry 43:14832-9. 2004..These effects are likely mediated by binding of blebbistatin within the myosin cleft that progressively closes in forming the acto-myosin rigor state...
Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx miceElisabeth R Barton
Department of Physiology, University of Pennsylvania, Philadelphia, PA 19104, USA
J Cell Biol 157:137-48. 2002..These results suggest that a combination of promoting muscle regenerative capacity and preventing muscle necrosis could be an effective treatment for the secondary symptoms caused by the primary loss of dystrophin...
Inhibition of matrix metalloproteinase activity by TIMP-1 gene transfer effectively treats ischemic cardiomyopathyVasant Jayasankar
Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-4283, USA
Circulation 110:II180-6. 2004..The reduction in myocardial fibrosis may be primarily responsible for the improved diastolic function in treated animals. TIMP-1 overexpression is a promising therapeutic target for continued investigation...
Attenuation of skeletal muscle atrophy via protease inhibitionCarl A Morris
Dept. of Physiology and the Pennsylvania Muscle Institute, Univ. of Pennsylvania School of Medicine, A-700 Richards Bldg, 3700 Hamilton Walk, Philadelphia, PA 19104-6085, USA
J Appl Physiol 99:1719-27. 2005..Thus BBI is a candidate therapeutic agent to minimize skeletal muscle atrophy and loss of strength associated with disuse, cachexia, sepsis, weightlessness, or the combination of age and inactivity...
Adhesion-contractile balance in myocyte differentiationMaureen A Griffin
Biophysical Engineering Laboratory, 112 Towne Building, and Pennsylvania Muscle Institute, University of Pennsylvania, D-700 Richards Building, 3700 Hamilton Walk, Philadelphia, PA 19104, USA
J Cell Sci 117:5855-63. 2004..Myotubes in culture are thus clearly prestressed by myosin II, and this contractility couples to substrate compliance and ultimately influences actomyosin striation...
Cargo binding induces dimerization of myosin VIDenis Phichith
Department of Physiology, University of Pennsylvania School of Medicine, 3700 Hamilton Walk, Philadelphia, PA 19104 6085, USA
Proc Natl Acad Sci U S A 106:17320-4. 2009..Because, unexpectedly, a monomeric fragment of Dab2 triggers dimerization, it would appear that myosin VI is designed to function as a dimer in cells...
gamma-Sarcoglycan deficiency increases cell contractility, apoptosis and MAPK pathway activation but does not affect adhesionMaureen A Griffin
Pennsylvania Muscle Institute, University of Pennsylvania Medical Center, D 700 Richards Building, 3700 Hamilton Walk, Philadelphia, PA 19104 6083, USA
J Cell Sci 118:1405-16. 2005..We conclude that gammaSG normally moderates contractile prestress in skeletal muscle, and we propose a role for gammaSG in membrane-based signaling of the effects of prestress and sarcomerogenesis...
Gene transfer of hepatocyte growth factor attenuates postinfarction heart failureVasant Jayasankar
Department of Cardiothoracic Surgery, University of Pennsylvania School of Medicine, Pliladelphia, PA 19104, USA
Circulation 108:II230-6. 2003..This therapy may be useful as an adjunct or alternative to standard revascularization techniques in patients with ischemic heart failure...
Myosin VI dimerization triggers an unfolding of a three-helix bundle in order to extend its reachMonalisa Mukherjea
Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, 19104, USA
Mol Cell 35:305-15. 2009..This unconventional mechanism generates an extension of the lever arm of myosin VI...
Patterning, prestress, and peeling dynamics of myocytesMaureen A Griffin
Department of Chemical and Biomolecular Engineering, Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Biophys J 86:1209-22. 2004....
Fructose 1,6-diphosphate administration attenuates post-ischemic ventricular dysfunctionJeffrey E Cohen
University of Pennsylvania, School of Medicine, Department of Surgery, Philadelphia, PA 19104, USA
Heart Lung Circ 15:119-23. 2006..0369). CONCLUSIONS: The administration of the glycolytic intermediate, FDP, by intravenous injection, resulted in significantly improved myocardial function after ischemia and improved bioenergetics during ischemia...
Mutation of smooth muscle myosin causes epithelial invasion and cystic expansion of the zebrafish intestineKenneth N Wallace
Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, 19104, USA
Dev Cell 8:717-26. 2005..Furthermore, they suggest that high-throughput screens to identify regulators of cancer cell invasion may be feasible in zebrafish...
Myotubes differentiate optimally on substrates with tissue-like stiffness: pathological implications for soft or stiff microenvironmentsAdam J Engler
School of Engineering and Applied Science, University of Pennsylvania, Philadelphia, PA 19104, USA
J Cell Biol 166:877-87. 2004..These findings have major implications for in vivo introduction of stem cells into diseased or damaged striated muscle of altered mechanical composition...
Molecular extensibility of mini-dystrophins and a dystrophin rod constructNishant Bhasin
Pennsylvania Muscle Institute and Graduate Groups in Physics and Cell and Molecular Biology, University of Pennsylvania, Philadelphia, PA 19104, USA
J Mol Biol 352:795-806. 2005..The results thus reveal new modes of dystrophin flexibility that may prove central to functions of both dystrophin and mini-dystrophins...
Administration of a tumor necrosis factor inhibitor at the time of myocardial infarction attenuates subsequent ventricular remodelingMark F Berry
Department of Surgery, Division of Cardiothoracic Surgery, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
J Heart Lung Transplant 23:1061-8. 2004..05) and the relaxation time constant (14.6 +/- 0.6 vs 17.9 +/- 1.2 msec; p < 0.05). CONCLUSIONS: TNF inhibition after infarction reduced leukocyte infiltration and extracellular matrix turnover and preserved cardiac function...
Mesenchymal stem cell injection after myocardial infarction improves myocardial complianceMark F Berry
Division of Cardiothoracic Surgery, Department of Physiology, University of Pennsylvania School of Medicine, A700 Richards Bldg, 3700 Hamilton Walk, Philadelphia, PA 19104-6085, USA
Am J Physiol Heart Circ Physiol 290:H2196-203. 2006..Improving scarred heart muscle compliance could be a functional benefit of cellular cardiomyoplasty...
Research Grants
- Structure and Function of Myosin VIHUGH LEE SWEENEY; Fiscal Year: 2010..We propose that the regulated dimerization obviates the need to regulate motor activity. ..
- MYOSIN ISOZYMESHUGH LEE SWEENEY; Fiscal Year: 2010....
- Structure and Function of Myosin VIHUGH SWEENEY; Fiscal Year: 2006..determine which kinetic and structural features are necessary for processive movement and the large step size of myosin VI; and 3) delineate putative modes of regulation of the myosin VI motor. ..
- Muscle: Contractile Proteins GRC 2005HUGH SWEENEY; Fiscal Year: 2005..This will be a transitional conference in that the overall focus of the conference will be divided between the Molecular Basis of Muscle Contraction and the broader topic of the Design and Function of Molecular Motors. ..
- BIOENGINEERING RESEARCH PARTNERSHIP--MUSCULAR DYSTROPHYHUGH SWEENEY; Fiscal Year: 2004..Lee Sweeney, Ph.D.); and Section 3: development of non-invasive methods for monitoring therapeutic benefits of dystrophin gene transfer (directed by Glenn Walter, Ph.D.). ..
- Understanding and Preventing Disuse AtrophyHUGH SWEENEY; Fiscal Year: 2007..abstract_text> ..
- MYOSIN ISOZYMESHUGH SWEENEY; Fiscal Year: 2007....
- MYOSIN ISOZYMESHUGH SWEENEY; Fiscal Year: 2009....
- Structure and Function of Myosin VIHUGH SWEENEY; Fiscal Year: 2007..We propose that the regulated dimerization obviates the need to regulate motor activity. ..
- New Directions in Biology and Disease of Skeletal MuscleHUGH SWEENEY; Fiscal Year: 2003..Its foci on cellular and molecular aspects of skeletal muscle as they relate to health, disease and dysfunction should bring together researchers who do not often attend the same meetings. ..
- PHYSIOLOGY AND MYOSIN ISOZYMES OF SKELETAL MUSCLE FIBERSHUGH SWEENEY; Fiscal Year: 1993..Plasticity is relevant not only to normal adaptation to altered activity but also to adaptation that occurs in neuromuscular disease states...
- CORE--PROTEIN ENGINEERINGHUGH SWEENEY; Fiscal Year: 2002..In addition, proteins will be through a combination of heterologous expression using either baculovirus/SF9 cells or E. coli and through the purification of proteins from rabbit tissues. ..
- TRAINING IN MUSCLE BIOLOGYHUGH SWEENEY; Fiscal Year: 2003..This is evidenced by the many prominent scientists around the world, who have trained in this field at the University of Pennsylvania. ..
- MYOSIN ISOZYMESHUGH SWEENEY; Fiscal Year: 2003..In this manner we will begin to dissect the functional and structural domains of the myosin motor, within the framework of delineating the principles of myosin design and isoform diversity. ..
- IN VIVO STUDIES OF TROPONIN T FUNCTIONHUGH SWEENEY; Fiscal Year: 2002..Our findings will provide fundamental knowledge of the mechanisms of muscle contraction and a basis for development of gene and drug therapies for the treatment of HCM. ..
